orforglipron and retatrutide diabetes #glp #glp1 #obesity #liraglutide #semaglutide #tirzepatide # #orforglipron #fda #drug #elililly #ozempic #wegovy #mounjaro Orforglipron: Phase 3 Data Shows

The ultimate goal of this project was to produce a clinically useful pharmaceutical for the treatment of dementia including Alzheimer's disease

This appears to be a database with a commercial purpose, but I cannot identify what that purpose might be based on their web site

Noom Med supports a range of evidence-based weight management medications, including but not limited to: GLP-1s: Wegovy , Zepbound , Ozempic , Mounjaro , liraglutide (generic), and more Other meds: Metformin, Contrave , topiramate Youll work closely with your Noom Med clinician throughout treatment

GLP-1 receptor agonists the treatment of type 2 diabetes: state-of-the-art

Possible effects include: Loose or excess skin Fatigue Hair thinning Muscle loss (if not strength training) Gallbladder issues with rapid loss Nutrient deficiencies if diet is poor Most risks are reduced with gradual weight loss, adequate protein, strength training, and medical supervision